Clinical trial

A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia

NCT01407289

Study summary

ClinicalTrials.gov

A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Insulin Aspart, Insulin Glargine Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-06-01

PhasePHASE4

Conditions

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

Insulin Aspart, Insulin GlargineDRUG

Sponsors & collaborators

Medical University of Grazlead sponsor

Mapped research locations

GrazAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01407289 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.